About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
BMY - Bristol-Myers Squibb...| Previous Close | $58.11 | Open | $58.00 |
| Volume | 8.77M | Market Cap | 131.485B |
| Yield | 2.96 % | Last Dividend | $1.72 |
| Dragonfly Therapeutics Announces New Res... | 07/06/20 |
| Dragonfly expands beyond existing collaboration with Bristol Myers Squibb in oncology and autoimmune disease to develop drug candidates against multip... | |
| Bristol Myers Squibb : Investor Series P... | 06/25/20 |
| Investor Series Hematology June 25, 2020 Forward Looking Statement and Non-GAAP Financial??? | June 25, 2020 | |
| BioGeneration Ventures : Closes BGV IV F... | 06/24/20 |
| Investors include Bristol Myers Squibb, European Investment Fund, Industriens Pension, KfW Capital, Schroder Adveq Investment focus on entrepreneurial... | |
| Bristol Myers Squibb (BMY) is a Top Divi... | 06/23/20 |
| Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol Myers Squibb (BMY) hav... | |
| The pandemic is making it harder for dru... | 06/19/20 |
| The coronavirus pandemic delayed other potentially life-saving medicines from beginning clinical trials, and it may delay them from hitting the market... | |
| Publisher and National Literacy Trust do... | 06/19/20 |
| More than 26,000 brand new books are being gifted to children and adults across Hastings and St Leonards, thanks to Bloomsbury Publishing and the Nati... | |
| ArcherDX Enters Collaboration with Brist... | 06/18/20 |
| BOULDER, Colo., June 18, 2020 /PRNewswire/ -- ArcherDX, Inc. today announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to ut... | |
| Bristol Myers Squibb to Announce Results... | 06/18/20 |
| NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb to Announce Results for Second Quarter 2020 on August 6, 2020 | |
| Ubiquigent Continues Drug Discovery Coll... | 06/17/20 |
| DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent expands drug discovery collaboration with Bristol Myers Squibb | |
| Bristol Myers Squibb Announces Commencem... | 06/16/20 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb Announces Commencement of Registered Exchange Offers | |
| UbiVac Announces Clinical Trial Collabor... | 06/09/20 |
| UbiVac, Inc. (www.ubivac.com) today announced it has entered into a clinical trial collaboration with Bristol Myers Squibb (NYSE:BMY) to evaluate the | |
| Wall Street lays out 3 key reasons to do... | 06/08/20 |
| Wall Street analysts are skeptical that an AstraZeneca-Gilead megamerger can be done. The British pharma giant AstraZeneca approached Gilead last mont... | |
| Bristol Myers Squibb to Take Part in 41s... | 06/04/20 |
| NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb to Take Part in 41st Annual Goldman Sachs Global Healthcare Conference | |
| Bristol Myers Reveals Positive Results F... | 06/02/20 |
| Bristol Myers Squibb (BMY) has announced positive results from True North, a pivotal Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction ... | |
| Bristol Myers Squibb Announces Positive ... | 06/02/20 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--BMS Announces Positive Topline Results from Pivotal Phase 3 True North Trial Evaluating Zeposia in Pat... | |
| Bristol Myers Squibb Announces Commercia... | 06/01/20 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA??, a New Oral Treatment f... | |
| Bristol Myers Squibb to Hold Virtual Thr... | 05/29/20 |
| NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb to Hold Virtual Three-Part Investor Series | |
| Bristol Myers Squibb Receives European C... | 05/27/20 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--BMS Receives European Commission Approval for Zeposia for Treatment of Adult Patients with Relapsing R... | |
| Exscientia raises $60m Series C - UKTN (... | 05/26/20 |
| Exscientia, the world leading artificial intelligence (AI) drug discovery company, today announced it has raised $60 million in a Series C financing r... | |
| EMA accepts Bristol Myers applications f... | 05/22/20 |
| The European Medicines Agency (EMA) has accepted for review Bristol Myers Squibb's (NYSE:BMY) marketing applications for two blood disorder treatments... | |
| Global Book Publishers Industry Report 2... | 05/19/20 |
| DUBLIN--(BUSINESS WIRE)--The "Book Publishers (GLOBAL) - Industry Report" report has been added to ResearchAndMarkets.com's offering. This report prov... | |
| Bristol Myers Squibb : FDA Approves Anot... | 05/15/20 |
| By Josh Beckerman Bristol-Myers Squibb said the U.S. Food and Drug Administration has approved a fifth indication for the combination of Opdivo and Ye... | |
| U.S. Food and Drug Administration Approv... | 05/15/20 |
| PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #AIDS--U.S. Food and Drug Administration Approves Bristol Myers Squibb???s Pomalyst?? (pomalidomide) for AID... | |
| Baupost moves: Adds Alphabet, Facebook; ... | 05/15/20 |
| Seth Klarman???s hedge fund Baupost Group as of March 31 disclosed new positions in Alphabet (GOOG, GOOGL) and Facebook (NASDAQ:FB), each weighing alm... | |
| Bristol Myers Squibb and bluebird bio to... | 05/13/20 |
| PRINCETON, N.J., & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BMY #ASCO20--BMS & bluebird bio to Present Updated Positive Results from Pivotal KarMMa Stud... | |
| Bristol Myers Squibb and bluebird bio Pr... | 05/13/20 |
| PRINCETON, N.J., & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $BMY #BMS--BMS and bluebird bio Provide Regulatory Update on Idecabtagene Vicleucel (ide-cel,... | |
| Bristol Myers Squibb CEO Giovanni Cafori... | 05/12/20 |
| CNBC???s Jim Cramer interviews Bristol Myers Squibb Chairman and CEO Giovanni Caforio from CNBC???s Healthy Returns Summit today Q1 2020 hedge fund le... | |
| Bristol Myers Squibb to Take Part in the... | 05/12/20 |
| NEW YORK--(BUSINESS WIRE)---- $BMY--Bristol Myers Squibb to Take Part in the UBS Virtual Global Healthcare Conference | |
| GRYT Health and Bristol Myers Squibb Tea... | 05/12/20 |
| ROCHESTER, N.Y. & PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #AdvocacyExchange--GRYT Health and Bristol Myers Squibb Team Up to Launch COVID Advocacy E... | |
| bluebird bio Announces Amended BCMA CAR-... | 05/11/20 |
| CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) today announced that it has amended its existing co-promotion/co-development agre... | |
| Buy rating | 05/07/20 |
| CFRA maintains Buy rating and raises Price Target from $69.00 to $70.00 | |
| Date | 2020-05-07 (BMO) | Est. (EPS/Rev.) | $1.49/ 10.02B |
| Actual (EPS/Rev.) | $1.72/ $10.78 B | EPS (TTM) | 0.81 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Options Eagle | George | 79.00 % | Follow |
| Option Superstars | James Catzen | 75.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Options Marc | Marc M | 55.00 % | Follow |
| Best Trading Ideas | Best Trading Ideas | 53.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
